Results 141 to 150 of about 20,895 (217)

Pharmacokinetic modelling of MRI-based liver function for risk assessment in primary sclerosing cholangitis: a prospective pilot study. [PDF]

Eur Radiol Exp
Bartholomä WC, Cai S, Simonsson C, Karlsson M, Kechagias S, Woisetschläger M, Dahlström N, Lundberg P.   +7 more
europepmc   +1 more source

Syntrophic interactions driving anaerobic methane oxidation in deep-sea cold seeps revealed by DNA-SIP. [PDF]

iScience
Jiang Q, Liu H, Jing H, Zhang Y.
europepmc   +1 more source

Treating Severe Obesity: A Medical Perspective. [PDF]

Adv Ther
Paknikar S, Muthusamy K.
europepmc   +1 more source

Management of acute otitis media with otorrhea in Italian pediatric practice: a national survey. [PDF]

Ital J Pediatr
Marchisio P, Miraglia Del Giudice M, d'Avino A, Zampogna S, Ciprandi G, Marseglia G.   +5 more
europepmc   +1 more source

Epigallocatechin-3-Gallate, the green tea polyphenol suppresses expression of CD31 and VEGFR2 and enhances the chemotherapeutic potential of irinotecan in AOM/DSS model of colorectal cancer in mice. [PDF]

J Egypt Natl Canc Inst
Rahman SS, Baruah S, Akhtara N, Nath JK, Bharali MK.   +4 more
europepmc   +1 more source

Anti-obesity medications and cognitive disorder risk: a discrepancy between RCTs and real-world evidence. [PDF]

Front Pharmacol
Li C, Lin C, Li Z, Lv F, Yang W, Ji L, Cai X.   +6 more
europepmc   +1 more source

GLP-1 receptor agonists in primary care: readiness, equity, and the risk of a two-tiered obesity treatment landscape. [PDF]

Ther Adv Endocrinol Metab
Ahmed MM, Nazari R, Othman ZK, Musa SS, Okesanya OJ, Adebayo UO, Branda F, Elmi AH, Lucero Prisno DE.   +8 more
europepmc   +1 more source

Efficacy and Safety of Anti-Obesity Medications for Weight Loss Maintenance in Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. [PDF]

Diabetes Obes Metab
Chen Z, Cheng R, Wang H, Hu F.
europepmc   +1 more source

Targeting the NAT1-ENO1-Lactate Axis Destabilizes PD-L1 to Reinvigorate Antitumor Immunity in Colorectal Cancer. [PDF]

MedComm (2020)
Liu YX, Wu WX, Zang Y, Hu G, Guo X, Wang Y, Yang Y, Jiang Z, Li XM, Liu F, Wu YY, Pan ZD, Hu YM, Zhang RY, Zhang HY, Chang PA, He XS, Gan WJ, Wu H.   +18 more
europepmc   +1 more source

LRMDA promotes intestinal mucosal barrier integrity and limits colitis and colon cancer. [PDF]

iScience
Yang L, Guo Y, Xiao B, Wang D, Zhong B, Zhang ZD, Lin D.   +6 more
europepmc   +1 more source